Management of Toxicities Related to Androgen Deprivation Therapy (ADT)
Richard Lam, MD - Prostate Oncology Specialists
In this presentation, Dr. Lam points out that prostate cancer patients
suffering a relapse have a much longer life expectancy than patients
with many other types of cancer. Androgen
deprivation therapy (ADT,
also called hormone blockade or testosterone inactivating pharmaceuticals)
is a primary treatment of recurrent prostate cancer. It can have toxicities
(side effects), but many of these toxicities can be reduced or eliminated
through combinations of medication, diet, and lifestyle changes.
Among the ADT side effects, and related counter strategies, that Dr.
Lam discusses are bone
mineral density loss, anemia, loss of libido, hot flashes,
muscle mass loss, increased sugar and cholesterol levels, breast enlargement
memory loss, and liver damage.
This presentation was one of several given at the Prostate
Cancer Research Instituteâ€™s September, 2006 conference “Improving
Treatment and Quality of Life For Men with Recurrent and Advanced Prostate
Cancer” held in Los Angeles, CA, USA. The Prostate Cancer Research
Institute (PCRI) is a 501(c)(3) charitable organization whose mission
is to improve the quality of menâ€™s lives by supporting research
and disseminating information that educates and empowers patients,
families and the medical community.
Much more information is available in our PCRI
Papers page and elsewhere on this Web site.
More videos are listed in our Online